Merck Sharp & Dohme Corp. v. Mylan Laboratories Limited > Summary
Court Case Number 1:18-cv-00450
Filing Date Mar 23, 2018
Termination Date Jul 15, 2019
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesMaryellen Noreika
Plaintiff
Defendant
Plaintiff Attorneys
7Merck Sharp & Dohme
Attorney Name: Tracey B. Davies
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: Michael P. Kelly
McCarter & English
Merck Sharp & Dohme
Attorney Name: Daniel M. Silver
McCarter & English
Merck Sharp & Dohme
Attorney Name: Michael A. Valek
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: Josh A. Krevitt
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: Blair A. Silver
Gibson Dunn & Crutcher
Merck Sharp & Dohme
Attorney Name: Jill M. McCormack
Gibson Dunn & Crutcher
Defendant Attorneys
9Viatris Inc.
Attorney Name: Sharad K. Bijanki
Parker Poe Adams & Bernstein
Viatris Inc.
Attorney Name: Michael L. Binns
Parker Poe Adams & Bernstein
Viatris Inc.
Attorney Name: Karen L. Carroll
Parker Poe Adams & Bernstein
Viatris Inc.
Attorney Name: Melanie B. Dubis
Parker Poe Adams & Bernstein
Viatris Inc.
Attorney Name: Robert L. Florence
Parker Poe Adams & Bernstein
Viatris Inc.
Attorney Name: David E. Moore
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: Stephanie O'Byrne
Potter Anderson & Corroon
Viatris Inc.
Attorney Name: Bindu A. G. Palapura
Potter Anderson & Corroon
Attorney Name: Melanie B. Dubis
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09358297 | Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin | Jun 7, 2016 |
| 09023790 | Posaconazole intravenous solution formulations stabilized by substituted β-cyclodextrin | May 5, 2015 |
